ahlam1399
09-12-2016, 06:23 PM
FDA staff flags concerns about Pfizer?s quit-smoking drug study
(Reuters) – U.S. Food and Drug Administration scientists have expressed concerns about a post-marketing study of Pfizer Inc’s drug Chantix, which is aimed at helping *****rs quit, according to documents posted on the regulator’s website.http://feeds.feedburner.com/~ff/reuters/healthNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/healthNews?a=Y5s6KXKTdu4:4JeGsr5fAxk:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/healthNews?i=Y5s6KXKTdu4:4JeGsr5fAxk:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/healthNews?a=Y5s6KXKTdu4:4JeGsr5fAxk:F7zBnMyn0Lo) http://feeds.feedburner.com/~ff/reuters/healthNews?i=Y5s6KXKTdu4:4JeGsr5fAxk:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/healthNews?a=Y5s6KXKTdu4:4JeGsr5fAxk:V_sGLiPBpWU)
http://feeds.feedburner.com/~r/reuters/healthNews/~4/Y5s6KXKTdu4
(Reuters) – U.S. Food and Drug Administration scientists have expressed concerns about a post-marketing study of Pfizer Inc’s drug Chantix, which is aimed at helping *****rs quit, according to documents posted on the regulator’s website.http://feeds.feedburner.com/~ff/reuters/healthNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/healthNews?a=Y5s6KXKTdu4:4JeGsr5fAxk:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/healthNews?i=Y5s6KXKTdu4:4JeGsr5fAxk:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/healthNews?a=Y5s6KXKTdu4:4JeGsr5fAxk:F7zBnMyn0Lo) http://feeds.feedburner.com/~ff/reuters/healthNews?i=Y5s6KXKTdu4:4JeGsr5fAxk:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/healthNews?a=Y5s6KXKTdu4:4JeGsr5fAxk:V_sGLiPBpWU)
http://feeds.feedburner.com/~r/reuters/healthNews/~4/Y5s6KXKTdu4